Delaware
|
001-38599
|
82-3827296
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
AQST
|
Nasdaq Global Market
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
Item 2.03 |
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant.
|
Item 9.01 |
Financial Statements and Exhibits
|
(d) |
Exhibits.
|
Exhibit Number
|
Description
|
|
Fifth Supplemental Indenture, dated May 13, 2022, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank Trust Company, National Association, as
Trustee and Collateral Agent
|
||
Amendment No. 2 to the Purchase Agreement, dated as of May 13, 2022, by and among the Aquestive Therapeutics, Inc. and the Purchasers signatory thereto
|
Dated: May 17, 2022
|
Aquestive Therapeutics, Inc.
|
|
By:
|
/s/ A. Ernest Toth, Jr.
|
|
Name: A. Ernest Toth, Jr.
|
||
Title: Chief Financial Officer
|
AQUESTIVE THERAPEUTICS, INC.
|
||
By:
|
/s/ Keith Kendall
|
|
Name: Keith Kendall
|
||
Title: President & CEO
|
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,
|
|||
as Trustee
|
|||
By:
|
/s/ Alison D.B. Nadeau
|
||
Name: Alison D.B. Nadeau
|
|||
Title: Vice President
|
|||
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,
|
|||
as Collateral Agent
|
|||
By:
|
/s/ Alison D.B. Nadeau
|
||
Name: Alison D.B. Nadeau
|
|||
Title: Vice President
|
AQUESTIVE THERAPEUTICS, INC.
|
||
By:
|
/s/Keith Kendall
|
|
Name:Keith Kendall
|
||
Title: President & CEO
|
MADRYN HEALTH PARTNERS (CAYMAN MASTER), LP
|
||
By: MADRYN HEALTH ADVISORS, LP, its General Partner
|
||
By: MADRYN HEALTH ADVISORS GP, LLC, its General Partner
|
||
By:
|
/s/ Avinash Amin
|
|
Name: Avinash Amin
|
||
Title: Member
|
||
MADRYN HEALTH PARTNERS, LP
|
||
By: MADRYN HEALTH ADVISORS, LP, its General Partner
|
||
By: MADRYN HEALTH ADVISORS GP, LLC, its General Partner
|
||
By:
|
/s/ Avinash Amin
|
|
Name: Avinash Amin
|
||
Title: Member
|
||
FFI FUND LTD.
|
||
By:
|
/s/ John N. Spinney, Jr.
|
|
Name: John N. Spinney, Jr.
|
||
Title: Authorized Signatory
|
||
OLIFANT FUND, LTD.
|
||
By:
|
/s/ John N. Spinney, Jr.
|
|
Name: John N. Spinney, Jr.
|
||
Title: Authorized Signatory
|
||
FYI LTD.
|
||
By:
|
/s/ John N. Spinney, Jr.
|
|
Name: John N. Spinney, Jr.
|
||
Title: Authorized Signatory
|
MORGAN STANLEY & CO. LLC
|
||
By:
|
/s/ Brian McGowan
|
|
Name: Brian McGowan
|
||
Title: Authorized Signatory
|